TrialThe Lancet. Child & adolescent health2022

Efficacy and safety of methylphenidate and behavioural parent training for children aged 3-5 years with attention-deficit hyperactivity disorder: a randomised, double-blind, placebo-controlled, and sham behavioural parent training-controlled trial.

Luisa Shiguemi Sugaya et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.